{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:07:43Z","timestamp":1793070463046,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lungcan.2026.108915","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:45:49Z","timestamp":1768664749000},"page":"108915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventions"],"prefix":"10.1016","volume":"213","author":[{"given":"Erica","family":"Pietroluongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8322-475X","authenticated-orcid":false,"given":"Paolo Antonio","family":"Ascierto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.108915_b0005","doi-asserted-by":"crossref","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","author":"Engels","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108915_b0010","doi-asserted-by":"crossref","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","author":"Evoli","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108915_b0015","unstructured":"British Society for Immunology. Autoimmunity. London, 2016."},{"key":"10.1016\/j.lungcan.2026.108915_b0020","series-title":"classifications, History, Epidemiology, and Importance. Paraneoplastic Syndromes","first-page":"3","author":"Darnell","year":"2011"},{"key":"10.1016\/j.lungcan.2026.108915_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jtho.2018.01.013","article-title":"Thymic tumors: revisiting autoimmunity to give a chance to immunotherapy","volume":"13","author":"Girard","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108915_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.21037\/med.2018.10.04","article-title":"Investigating thymic epithelial tumor, the \u201csource\u201d of autoimmunity and immunodeficiency: a lesson from ITMIGRD","volume":"2","author":"Montella","year":"2018","journal-title":"Mediastinum"},{"issue":"9 Suppl 2","key":"10.1016\/j.lungcan.2026.108915_b0035","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1097\/JTO.0000000000000294","article-title":"Approaching the patient with an anterior mediastinal mass: a guide for clinicians","volume":"9","author":"Carter","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.108915_b0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108915_b0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtcvs.2019.11.052","article-title":"A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases","volume":"160","author":"Zhao","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1634\/theoncologist.11-8-887","article-title":"Thymoma: benign appearance, malignant potential","volume":"11","author":"Riedel","year":"2006","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.lungcan.2026.108915_b0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0025-6196(12)60907-0","article-title":"Thymoma","volume":"68","author":"Morgenthaler","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.lungcan.2026.108915_b0060","series-title":"Thymic Neoplasms: A Comprehensive Review of the Diagnosis, Classification, and Treatment","author":"Detterbeck","year":"2017"},{"issue":"12","key":"10.1016\/j.lungcan.2026.108915_b0065","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","article-title":"Autoimmune disorders and paraneoplastic syndromes in thymoma","volume":"12","author":"Blum","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2026.108915_b0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the international thymic malignancy interest group retrospective database","volume":"13","author":"Padda","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.108915_b0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ejcts\/ezt649","article-title":"Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database","volume":"46","author":"Ruffini","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2026.108915_b0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/JTO.0000000000000128","article-title":"Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database","volume":"9","author":"Ruffini","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"338\u201343","key":"10.1016\/j.lungcan.2026.108915_b0085","first-page":"17","article-title":"Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients","volume":"88","author":"Filosso","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.108915_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.athoracsur.2004.06.090","article-title":"Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan","volume":"79","author":"Kondo","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2026.108915_b0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.21037\/jtd.2016.02.07","article-title":"Postoperative survival for patients with thymoma complicating myasthenia gravispreliminary retrospective results of the ChART database","volume":"8","author":"Wang","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2026.108915_b0100","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/ejcts\/ezv380","article-title":"Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database","volume":"49","author":"Nakajima","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2026.108915_b0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"15_suppl","key":"10.1016\/j.lungcan.2026.108915_b0110","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1200\/JCO.2020.38.15_suppl.9073","article-title":"Prevalence of autoimmune diseases in thymic epithelial tumors (TET) insights from RYTHMIC","volume":"38","author":"Benitez","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.108915_b0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/08916930903555935","article-title":"Thymoma and paraneoplastic myasthenia gravis","volume":"43","author":"Marx","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lungcan.2026.108915_b0120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ejcts\/ezy448","article-title":"Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours","volume":"55","author":"Ruffini","year":"2019","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ejcts\/ezaa362","article-title":"Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: analysis of a Japanese multi-institutional retrospective database","volume":"59","author":"Hishida","year":"2021","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108915_b0130","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt Sinai J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thorsurg.2018.12.001","article-title":"The role of the thymus in the immune response","volume":"29","author":"Thapa","year":"2019","journal-title":"Thorac. Surg. Clin."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2002-08-2545","article-title":"Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients","volume":"102","author":"Markert","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lungcan.2026.108915_b0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cei.12088","article-title":"Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3-T cells in complete DiGeorge anomaly","volume":"173","author":"Chinn","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.108915_b0150","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.181.4.2265","article-title":"Thymic emigration: when and how T cells leave home","volume":"181","author":"Weinreich","year":"2008","journal-title":"J. Immunol."},{"issue":"38","key":"10.1016\/j.lungcan.2026.108915_b0155","doi-asserted-by":"crossref","first-page":"16613","DOI":"10.1073\/pnas.1004623107","article-title":"Thymopoiesis in mice depends on a Foxn1-positive thymic epithelial cell lineage","volume":"107","author":"Corbeaux","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.lungcan.2026.108915_b0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.coi.2011.05.001","article-title":"Altered thymic activity in early life: how does it affect the immune system in young adults?","volume":"23","author":"Sauce","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108915_b0165","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.immuni.2018.04.015","article-title":"A single-cell transcriptomic atlas of thymus organogenesis resolves cell types and developmental maturation","volume":"48","author":"Kernfeld","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2008.08.007","article-title":"Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity","volume":"29","author":"Irla","year":"2008","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.lungcan.2026.108915_b0175","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni.3537","article-title":"Foxn1 regulates key target genes essential for T cell development in postnatal thymic epithelial cells","volume":"17","author":"Zuklys","year":"2016","journal-title":"Nat. Immunol."},{"issue":"1\u20133","key":"10.1016\/j.lungcan.2026.108915_b0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-012-8301-y","article-title":"Thymic epithelial cells: antigen presenting cells that regulate T cell repertoire and tolerance development","volume":"54","author":"Alexandropoulos","year":"2012","journal-title":"Immunol. Res."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0185","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1084\/jem.20040581","article-title":"Gene dosage\u2013limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity","volume":"200","author":"Liston","year":"2004","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.lungcan.2026.108915_b0190","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nri2450","article-title":"Transcriptional regulation by AIRE: molecular mechanisms of central tolerance","volume":"8","author":"Peterson","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.108915_b0195","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1084\/jem.20070795","article-title":"Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire","volume":"204","author":"Gray","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2005.07.005","article-title":"The cellular mechanism of Aire control of T cell tolerance","volume":"23","author":"Anderson","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.lungcan.2026.108915_b0205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/clim.1999.4710","article-title":"Correlation of thymic pathology with HLA in myasthenia gravis","volume":"91","author":"Machens","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lungcan.2026.108915_b0210","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2026.108915_b0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic Landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.lungcan.2026.108915_b0220","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/JTO.0000000000000215","article-title":"Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma","volume":"9","author":"Safieddine","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3988\/jcn.2012.8.3.161","article-title":"Incidence of thymoma in myasthenia gravis: a systematic review","volume":"8","author":"Mao","year":"2012","journal-title":"J. Clin. Neurol. (Seoul, Korea)"},{"issue":"5","key":"10.1016\/j.lungcan.2026.108915_b0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nmd.2017.01.023","article-title":"Seronegative myasthenia gravis associated with malignant thymoma","volume":"27","author":"Richards","year":"2017","journal-title":"Neuromuscular Disord."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.nmd.2008.06.368","article-title":"Two cases of thymomaassociated myasthenia gravis without antibodies to the acetylcholine receptor","volume":"18","author":"Maggi","year":"2008","journal-title":"Neuromuscular Disord."},{"issue":"5","key":"10.1016\/j.lungcan.2026.108915_b0240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108915_b0245","first-page":"511","article-title":"Randomized trial of thymectomy in myasthenia gravis.NEngl","volume":"375","author":"Wolfe","year":"2016","journal-title":"J. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2026.108915_b0250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.108915_b0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108915_b0260","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis","volume":"41","author":"Gajdos","year":"2012","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.108915_b0265","first-page":"e1117","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"95","author":"Hehir","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.lungcan.2026.108915_b0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomized, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2020","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0275","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10072-024-07861-6","article-title":"Eculizumab in refractory myasthenia gravis: a real-world single-center experience","volume":"46","author":"Ricciardi","year":"2025","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.lungcan.2026.108915_b0280","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/acn3.51376","article-title":"Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses","volume":"8","author":"Howard","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0285","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1007\/s00415-023-11699-x","article-title":"Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension","volume":"270","author":"Meisel","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.lungcan.2026.108915_b0290","doi-asserted-by":"crossref","unstructured":"J.F. Howard, Jr, V. Bril, T. Vu, et al. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial [published correction appears in Lancet Neurol. 2021 Aug;20(8):e5. doi: 10.1016\/S1474-4422(21)00216-7]. Lancet Neurol. 2021;20(7):526-536. doi:10.1016\/S1474-4422(21)00159-9.","DOI":"10.1016\/S1474-4422(21)00159-9"},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12185-018-02573-y","article-title":"Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration","volume":"109","author":"Kobayashi","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0300","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.21037\/jtd.2018.07.14","article-title":"Pure red cell aplasia associated with thymoma: a report of a single-center experience","volume":"10","author":"Moriyama","year":"2018","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108915_b0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymomaassociated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.lungcan.2026.108915_b0310","doi-asserted-by":"crossref","first-page":"AB003","DOI":"10.21037\/med.2017.AB003","article-title":"New proposed treatment for pure red cell aplasia thymoma-related","volume":"1","author":"Palmieri","year":"2017","journal-title":"Mediastinum"},{"issue":"5","key":"10.1016\/j.lungcan.2026.108915_b0315","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lungcan.2026.108915_b0320","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2020.12.010","article-title":"Immunodeficiency and thymoma in good syndrome: two sides of the same coin","volume":"231","author":"Guevara-Hoyer","year":"2021","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4081\/cp.2019.1112","article-title":"Good\u2019s syndrome, a rare form of acquired immunodeficiency associated with thymomas","volume":"9","author":"Tamburello","year":"2019","journal-title":"Clinics Pract."},{"issue":"May","key":"10.1016\/j.lungcan.2026.108915_b0330","first-page":"1","article-title":"When the good syndrome goes bad: a systematic literature review","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0335","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-020-05575-6","article-title":"Response to: caution the masqueraders of good\u2019s syndrome on the thymoma with systemic lupus erythematosus","volume":"40","author":"Mollaeian","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.108915_b0340","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.1402805","article-title":"A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression","volume":"194","author":"Christopoulos","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0345","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of diseases associated with thymoma. Coincidence or syndrome?","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2026.108915_b0350","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archinte.1984.00350160117020","article-title":"Disorders of the thymus: a review","volume":"144","author":"Rosenow","year":"1984","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0355","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","article-title":"Good\u2019s syndrome remains a mystery after 55 years: a systematic review of the scientific evidence","volume":"135","author":"Kelesidis","year":"2010","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"issue":"2","key":"10.1016\/j.lungcan.2026.108915_b0360","first-page":"86","article-title":"Immunological findings in thymoma-related syndromes","volume":"31","author":"Masci","year":"1999","journal-title":"Ann. Med."},{"key":"10.1016\/j.lungcan.2026.108915_b0365","first-page":"437","article-title":"Pre-B cell suppression by thymoma patient lymphocytes","volume":"48","author":"Hayward","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lungcan.2026.108915_b0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jcp.s3-13.1.5","article-title":"Pathogenesis hypogammaglobulinaemia with thymoma and late-onset hypogammaglobulinaemia","volume":"13","author":"Asherson","year":"1979","journal-title":"J. Clin. Pathol. Suppl. (R. Coll. Pathol.)"},{"issue":"8","key":"10.1016\/j.lungcan.2026.108915_b0375","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-08-2638","article-title":"Clonal expansion of CD8 BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia","volume":"101","author":"Masci","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2026.108915_b0380","unstructured":"A. Tamburello, L. Castelnovo, P. Faggioli, et al. Good\u2019s syndrome, a rare form of acquired immunodeficiency associated with thymomas. Clin Pract 2019;9:1112. Malfitano AM, D'Esposito V, De Placido P, Tortora M, Ottaviano M, Pietroluongo E, Morra R, Mucci B, Napolitano F, Montella L, Giuliano M, De Placido S, Terracciano D, Palmieri G, Formisano P. Immunological signature of patients with thymic."},{"issue":"13","key":"10.1016\/j.lungcan.2026.108915_b0385","article-title":"Immunological signature of patients with thymic epithelial tumors and good syndrome","volume":"18","author":"Malfitano","year":"2022","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.108915_b0390","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jtho.2023.06.015","article-title":"Impaired seroconversion after severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with thymic epithelial tumors","volume":"18","author":"Pietroluongo","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.108915_b0395","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12885-024-12405-4","article-title":"COVID-19 in patients with thymic epithelial tumors with or without Good\u2019s syndrome: a single-center retrospective study","volume":"24","author":"Pietroluongo","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2026.108915_b0400","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/med-21-47","article-title":"Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic","volume":"7","author":"Pietroluongo","year":"2022","journal-title":"Mediastinum"},{"key":"10.1016\/j.lungcan.2026.108915_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1233056","article-title":"Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response","volume":"14","author":"Cernera","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0410","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol."},{"issue":"24","key":"10.1016\/j.lungcan.2026.108915_b0415","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial","volume":"37","author":"Cho","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.108915_b0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(25)00001-4","article-title":"Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial","volume":"26","author":"Shukuya","year":"2025","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.108915_b0425","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/emp2.12209","article-title":"Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department","volume":"1","author":"Yeung","year":"2020","journal-title":"J. Am. Coll. Emerg. Physicians Open"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T18:04:14Z","timestamp":1774029854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":85,"alternative-id":["S0169500226000103"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.108915","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventions","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.108915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108915"}}